You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company is hoping its technology can help predict which melanoma patients will respond to checkpoint inhibition using immune-related gene expression signals.
The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.
Researchers from Protagen, Targos, and elsewhere have identified autoantibody biomarkers specific to patients diagnosed with prostate cancer.
Researchers in Belgium and the UK showed that their custom viral panel on Thermo Fisher's TaqMan qPCR array card is effective in samples from immunocompromised patients.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
CEO Lars Kongsbak said that the proceeds will be used to strengthen the company's capital resources and to expand its inventory in light of growing demand for its qPCR arrays, miRcury microRNA microarrays, and other products and services.
Lonza is distributing Bar Harbor BioTechnology's new tools under an exclusive agreement.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
Wired reports that Oxitec has now developed a genetically modified fall armyworm.
A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.